Free alanine, aspartic acid, or glutamic acid reduce the glycation of human lens proteins
- 1 August 1996
- journal article
- research article
- Published by Springer Nature in Glycoconjugate Journal
- Vol. 13 (4) , 519-523
- https://doi.org/10.1007/bf00731438
Abstract
The amino acids lysine and glycine are reported to react with glucose at physiological pH and temperature and undergo non-enzymic glycation. Three other amino acids present in relatively larger amounts in the lens i.e. alanine, aspartic acid and glutamic acid were also found to undergo non-enzymic glycation as found by incorporation of uniformly labelled (U-[14C]) glucose into the amino acids. The glucose incorporation was 1.6 to 2.5% for alanine, 35 to 50% for aspartic acid and 2.3 to 3.3% for glutamic acid. Each amino acid of varying concentrations lowered the extent ofin vitro glycation of lens proteins significantly in glucose-treated homogenates of normal lens from humans. The decrease in glycation for alanine was between 32 and 69%, that for aspartate was between 18 and 74%, and for glutamate was between 52 to 74%. Decreased glycation was greater for higher concentrations of glucose. Scavenging of intracellular glucose and decreasing the extent of glycation of lens proteins could be the mechanism of action by which the amino acids alanine, aspartic acid and glutamic acid could exercise a beneficial effect on cataract and diabetic retinopathy.Keywords
This publication has 9 references indexed in Scilit:
- XI International Congress of Eye ResearchExperimental Eye Research, 1994
- Decrease in Glycation of Lens Proteins by Lysine and Glycine by Scavenging of Glucose and Possible Mitigation of CataractogenesisExperimental Eye Research, 1993
- Glycation (non-enzymic glycosylation) inactivates glutathione reductaseBiochemical Journal, 1992
- Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofenExperimental Eye Research, 1992
- Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline.Journal of Clinical Investigation, 1992
- On the Pathogenesis of Diabetic RetinopathyOphthalmology, 1991
- Physiology, biochemistry, pathogenesis, and epidemiology of cataractCurrent Opinion in Opthalmology, 1991
- Biochemistry of the EyePublished by Springer Nature ,1991
- INHIBITION OF LENS CRYSTALLIN GLYCATION AND HIGH MOLECULAR-WEIGHT AGGREGATE FORMATION BY ASPIRIN INVITRO AND INVIVO1989